Free Trial
TSE:HLS

HLS Therapeutics (HLS) Stock Price, News & Analysis

HLS Therapeutics logo
C$4.90 +0.02 (+0.41%)
As of 01:32 PM Eastern

About HLS Therapeutics Stock (TSE:HLS)

Key Stats

Today's Range
C$4.85
C$4.90
50-Day Range
C$4.24
C$5.05
52-Week Range
C$3.00
C$5.23
Volume
3,401 shs
Average Volume
13,407 shs
Market Capitalization
C$109.01 million
P/E Ratio
N/A
Dividend Yield
4.08%
Price Target
C$4.50
Consensus Rating
Hold

Company Overview

Receive HLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

HLS Stock News Headlines

HLS Therapeutics Reports Annual Meeting Results
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
HLS Therapeutics Announces Q1 2025 Financial Results
HLS Therapeutics Inc (HLS) Receives a Hold from Stifel Nicolaus
See More Headlines

HLS Stock Analysis - Frequently Asked Questions

HLS Therapeutics' stock was trading at C$3.93 at the beginning of 2025. Since then, HLS shares have increased by 24.7% and is now trading at C$4.90.

HLS Therapeutics Inc. (TSE:HLS) posted its earnings results on Thursday, November, 7th. The company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.01. HLS Therapeutics had a negative trailing twelve-month return on equity of 25.27% and a negative net margin of 38.70%.
Read the conference call transcript
.

Shares of HLS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HLS Therapeutics investors own include Toronto-Dominion Bank (TD), Meta Platforms (META), NVIDIA (NVDA), CohBar (CWBR), Alphabet (GOOG), Great-West Lifeco (GWO) and ObsEva (OBSV).

Company Calendar

Last Earnings
11/07/2024
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:HLS
CIK
N/A
Fax
N/A
Employees
91
Year Founded
N/A

Price Target and Rating

High Price Target
C$5.00
Low Price Target
C$4.00
Potential Upside/Downside
-7.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$15.53 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$40.13 million
Cash Flow
C$0.32 per share
Price / Cash Flow
15.22
Book Value
C$2.51 per share
Price / Book
1.94

Miscellaneous

Free Float
N/A
Market Cap
C$108.57 million
Optionable
Not Optionable
Beta
1.07
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (TSE:HLS) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners